Silencing of SIRT2 induces cell death and a decrease in the intracellular ATP level of PC12 cells

Insights

Sirtuin 2 (SIRT2) reduction impairs PC12 cell energy and survival, increasing necrosis. SIRT2 is crucial for cellular energy metabolism and basal survival, impacting Parkinson's disease models.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Sirtuin 2 (SIRT2) is a tubulin deacetylase implicated in cellular processes.
  • SIRT2 inhibition shows promise in Parkinson's disease models by reducing cell death.
  • Potential negative impacts of SIRT2 reduction on cellular antioxidant capacity are noted.

Purpose of the Study:

  • To investigate the role of Sirtuin 2 (SIRT2) in cellular energy metabolism and survival.
  • To determine the effect of SIRT2 modulation on PC12 cell ATP levels and necrosis.
  • To evaluate the impact of a selective SIRT2 inhibitor (AGK2) on oxidative stress-induced ATP depletion.

Main Methods:

  • Silencing of SIRT2 in PC12 cells.
  • Treatment of PC12 cells with AGK2, a selective SIRT2 inhibitor.
  • Assessment of intracellular ATP levels and cell necrosis.
  • Evaluation of autophagy markers.

Main Results:

  • SIRT2 silencing decreased intracellular ATP levels in PC12 cells.
  • AGK2 exacerbated hydrogen peroxide-induced ATP reduction.
  • Reduced SIRT2 levels significantly increased PC12 cell necrosis.
  • Autophagy was not affected by SIRT2 reduction.

Conclusions:

  • SIRT2 plays a critical role in maintaining intracellular ATP levels.
  • SIRT2 is essential for basal survival and energy metabolism in PC12 cells.
  • Targeting SIRT2 may have complex effects on cellular health, impacting both cell death and energy levels.

Related Concept Videos

siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...